What CBC (Complete Blood Count) abnormalities are associated with lymphoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CBC Abnormalities in Lymphoma

The most common CBC abnormalities in lymphoma include anemia (seen in 32-42% of patients), thrombocytopenia (13%), leukopenia (6%), leukocytosis (26%), and thrombocytosis (14%). 1

Common CBC Findings in Lymphoma

Red Blood Cell Abnormalities

  • Anemia:
    • Present in 32-42% of non-Hodgkin lymphoma patients at diagnosis 2, 1
    • Usually mild with hemoglobin levels between 10-12 g/dL 3
    • Typically presents as anemia of chronic disease (71.7% of cases) 2
    • Often caused by inflammatory cytokines like IL-6 which increase hepcidin production, leading to iron restriction 3
    • Other causes include:
      • Iron deficiency (39.1% of cases) 2
      • Vitamin B12/folate deficiency (21.7% of cases) 2
      • Autoimmune hemolytic anemia (10.9% of cases) 2
      • Bone marrow infiltration (rarely the sole cause) 3, 2

White Blood Cell Abnormalities

  • Leukopenia: Found in 6% of NHL patients 1

    • More common with bone marrow involvement
    • May affect neutrophils, lymphocytes, or both
  • Leukocytosis: Present in 26% of NHL patients 1

    • Severe leukocytosis (WBC >20×10^9/L) associated with poor prognosis
    • May represent:
      • Reactive leukocytosis due to inflammation
      • Circulating lymphoma cells (seen in 9.5% of cases) 1

Platelet Abnormalities

  • Thrombocytopenia: Found in 13% of NHL patients 1

    • More common with bone marrow involvement
    • Associated with shorter survival in patients with bone marrow involvement
  • Thrombocytosis: Present in 14% of NHL patients 1

    • Usually reactive due to inflammatory cytokines

Multiple Cytopenias

  • Multiple cytopenias (affecting 2 or more cell lines) occur in approximately 8% of lymphoma patients 1
  • Leukoerythroblastosis (immature WBCs and nucleated RBCs in peripheral blood) seen in 2% of cases 1
  • Both findings are associated with poor prognosis

Prognostic Significance

  • Anemia is an independent adverse prognostic factor for overall survival and progression-free survival 4
  • Adding anemia to the International Prognostic Index improves prognostic accuracy 4
  • Severe leukocytosis (>20×10^9/L) correlates with shorter survival in patients without bone marrow involvement 1
  • Thrombocytopenia is associated with shorter survival in patients with bone marrow involvement 1

Specific Lymphoma Types and CBC Findings

  • Hodgkin Lymphoma: Anemia is common and typically presents as anemia of chronic disease 3
  • Chronic Lymphocytic Leukemia: Progressive cytopenias are common as disease advances 5
  • Intravascular Large B-cell Lymphoma: Often presents with cytopenias including anemia, thrombocytopenia, and mild leukopenia 6

Important Considerations

  • Anemia in lymphoma is often multifactorial (39.1% of cases) 2
  • Nutritional deficiencies are present in nearly half (47.8%) of anemic lymphoma patients 2
  • CBC abnormalities should be evaluated in the context of other clinical and laboratory findings
  • Bone marrow examination is essential when cytopenias are present to determine if lymphoma infiltration is contributing to the abnormalities

Remember that CBC abnormalities in lymphoma can reflect both direct effects of the disease (bone marrow infiltration) and indirect effects (cytokine-mediated changes, autoimmune phenomena, and nutritional deficiencies). The pattern and severity of these abnormalities provide valuable diagnostic and prognostic information.

References

Research

Prevalence and aetiology of anaemia in lymphoid malignancies.

The National medical journal of India, 2013

Research

Iron in Hodgkin's lymphoma.

Critical reviews in oncogenesis, 2013

Research

Frequency and significance of anemia in non-Hodgkin's lymphoma patients.

Annals of oncology : official journal of the European Society for Medical Oncology, 1998

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.